Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment

Autor: Anur Miah, Alexander M. Seifalian, Barry Fuller, Kevin M. Sales, Shi Yu Yang, Marc C. Winslet
Rok vydání: 2011
Předmět:
Zdroj: International Journal of Oncology.
ISSN: 1791-2423
1019-6439
DOI: 10.3892/ijo.2011.982
Popis: Colorectal cancer is the third most common cause of cancer-related deaths in the Western world. 5-Fluorouracil (5-FU) based chemotherapeutic regimes have been the mainstay of systemic treatment for disseminated colorectal cancer for many years. However, it only produces a 25% response rate due to the drug-resistance. The mitogen-activated protein kinase (MAPK) pathway is involved in the anti-apoptotic process; its activation provides cancer cells with a survival advantage to escape the apoptotic challenge. This study assessed whether the p38 MAPK pathway is involved in 5-FU resistance in colorectal cancer cells. 5-FU only or 5-FU combined with a p38 MAPK pathway inhibitor (SB203580) was used to treat 5-FU-resistant colorectal cancer cells. The effect of the treatment on cell viability, death and caspase activities was assessed. Western blotting was used to investigate the responses of apoptosis-related proteins following the treatment. Results showed that p38 MAPK inhibitor significantly increased colorectal cancer cell sensitivity to 5-FU. 513203580 in combination with 5-FU significantly reduced cell viability (P
Databáze: OpenAIRE